Teladoc Health to Expand Global Reach with Acquisition of MédecinDirect

Thursday, March 21, 2019

Teladoc Health, the global leader in virtual care, announces its agreement to acquire Paris-based telemedicine provider MédecinDirect. By combining the breadth of virtual care services of Teladoc Health with the strong, established local medical operations of MédecinDirect, the company is poised to capitalize on positive market conditions to bring the benefits of virtual care to more individuals across France.

“With a continued focus on our global expansion, we will now become the market leader in France with the ability to have an immediate impact on healthcare delivery in the country,” stated Carlos Nueno, president, Teladoc Health International. “On the successful foundation built by MédecinDirect, we will bring our full suite of virtual care services to multinational clients who have been eager to expand.”

Similar to many countries around the world, France also faces the growing demand for convenient access to high-quality healthcare. Consumer awareness of virtual care is on the rise, and the recent positive regulatory changes regarding virtual care reimbursement make the market ripe for virtual care adoption. With more than 40 leading insurance partners and nearly half of the top 30 private medical insurers (PMIs) in France, MédecinDirect has a well-established client base that can now benefit from access to a much broader spectrum of clinical services.

“We have had great success in the virtual care market, and now together with Teladoc Health we can meet more care needs for more individuals, and ultimately help improve healthcare across the country,” said Francois Lescure, CEO and co-founder, MédecinDirect.  “We share Teladoc Health’s vision for what the healthcare experience should be and look forward to transforming how people access healthcare.”

The acquisition is expected to close during the first half of the year and terms will not be disclosed. The organization will become the French country unit of Teladoc Health, adding to existing operations in the U.K., Australia, Canada, Spain, Portugal, Hungary, China, Chile and Brazil. The closing is subject to regulatory approval and the acquisition will be immaterial to Teladoc Health’s financial results.